Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 6.31M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -1.72M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -38.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -97.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -100.00% |
| Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 140.22M | 52W Low Chg | 400.00% |
| Insider Own | 1.43% | ROA | -897.88% | Shares Float | 139.83M | Beta | 4.42 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00090 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 2,328,241 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 2,038,695 | Change | 0.00% |
About CEREBAIN BIOTECH CORP
Cerebain Biotech Corp., a biomedical company, focuses on the discovery of products for the treatment of Alzheimer's disease. Its products would include medical device solutions, as well as synthetic drug solutions. The company was formerly known as Discount Dental Materials, Inc. and changed its name to Cerebain Biotech Corp. in June 2014. Cerebain Biotech Corp. was incorporated in 2007 and is headquartered in Costa Mesa, California.